Dermatology-focused healthcare services provider Sakhiya Skin has filed its Draft Red Herring Prospectus (DRHP) with the BSE to launch a small and medium enterprise (SME) IPO.
As per the DRHP, the IPO will comprise up to 61,72,000 equity shares, including a fresh issue of up to 50,10,000 shares and an offer for sale (OFS) of up to 11,62,000 shares.
Under the OFS, promoter Jagdishkumar Jadavbhai Sakhiya plans to sell up to 8,82,653 shares, while Rupalben Jagdishbhai Sakhiya intends to offload 2,79,347 shares.
🔹 Utilisation of Funds
- Around ₹4,257.73 lakhs will be used for opening new clinics across India.
- ₹88.50 lakhs will go towards technology and facility upgrades.
- ₹964.60 lakhs will be invested in its subsidiary Dr. Sakhiya’s Advanced Skin Science LLP.
- ₹320 lakhs will be utilised for partial repayment of borrowings.
- Remaining funds will be allocated to general corporate purposes.
GYR Capital Advisors Pvt Ltd is the sole book-running lead manager for the issue.
🔹 About the Company
Sakhiya Skin is a leading dermatology-focused healthcare provider offering skin, laser, hair, anti-ageing, dermato-surgery, and plastic surgery treatments. The company operates a network of 35 clinics across 24 cities, primarily in Gujarat and Maharashtra, and has served more than 5.4 lakh patients to date.
For FY 2025, the company reported revenue of ₹5,287.78 lakhs and a profit of ₹1,091.69 lakhs, reflecting a net margin of 20.6%. During the year, it treated 1,48,192 patients, including nearly 30,991 new patients, while its Dermato Cosmetic Clinic recorded almost 1,00,000 patient visits annually across its centres.
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or subscribe to any securities. Investors are advised to consult their financial advisors before making any investment decisions.
